Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, North America, Israel, and Africa.
He also reads “This New Year, I Resolve to Let Myself Hope” by Benjamin Hofmeister, from his column “Chairborne.”
